Adipex
Allegra
Ambien
Claritin
Flexeril
Meridia
Phendimetrazine
Propecia
Ultram
Viagra
Wellbutrin
|
 |
NEW MEDICATIONS
Below we offer details about some newly approved (by the FDA) medications and
their uses.
Focalin XR (dexmethylphenidate HCl) Extended-Release Capsules
Approved: May 26, 2005 Company: Novartis Pharmaceuticals Corporation
Treatment for: Attention-Deficit/Hyperactivity Disorder (ADHD)
Tramadol ODT (tramadol hydrochloride) Orally Disintegrating Tablets
Approved: May 5, 2005 Company: Biovail Corporation
Treatment for: Moderate to Moderately Severe Pain
Fosamax Plus D (alendronate sodium and cholecalciferol) Tablets
Approved: April 7, 2005 Company: Merck & Co., Inc.
Treatment for: Osteoporosis
Symlin (pramlintide acetate) Injection
Approved: March 16, 2005 Company: Amylin Pharmaceuticals, Inc.
Treatment for: Diabetes in conjunction with insulin
Clarinex-D 24 Hour (desloratadine and pseudoephedrine) ER Tablets
Approved: March 3, 2005 Company: Schering-Plough Corporation
Treatment for: Symptoms of Seasonal Allergic Rhinitis
Nascobal (cyanocobalamin) Nasal Spray
Approved: January 31, 2005 Company: Nastech Pharmaceutical Company Inc.
Treatment for: Vitamin B12 Deficiency
Niravam (alprazolam) Orally Disintegrating Tablets
Approved: January 19, 2005 Company: Schwarz Pharma AG
Treatment for: Anxiety Disorders
Femhrt 0.5 mg/2.5 mcg (norethindrone acetate/ethinyl estradiol)
Approved: January 17, 2005 Company: Warner Chilcott
Treatment for: Menopause
|
|
|
|
